At the NCT Heidelberg, more than 500 scientists, medical practitioners, and scientific, clinical, and administrative staff work continuously to advance cancer research and offer to our patients the best treatment possible. In doing so, we count on the latest methods and technologies. Here you can get an insight into some of the current approaches.
"By means of molecular profiling technologies, we try to find new therapeutic approaches for young patients with advanced cancer as well as patients with particularly rare tumors, as standard treatments no longer work in these cases."
Prof. Dr. Stefan Fröhling, Managing Director NCT Heidelberg and Head of the Division Translational Medical Oncology at the German Cancer Research Center
